A Phase I clinical trial of an experimental anticancer drug has begun, using a specialized virus designed to selectively attack the cells that make up the targeted tumor. A separate cancer study has also produced the unprecedented—yet very welcome—outcome of successfully treating the cancer that was present in all ofread more

Five million people globally have been confirmed to have died from COVID-19 since the first known patient was diagnosed with the SARS-like disease just 23 months ago in China. Infections from the fast-spreading coronavirus have now become the world’s third leading cause of death, after heart disease and stroke. Althoughread more

Medical research teams in England and China are reporting that COVID-19 vaccines being developed are prompting a protective immune response against the coronavirus in subjects that have been injected with the new formulations. This is good news, as other researchers have found that the antibodies produced from a direct infectionread more